Literature DB >> 11355130

Effects of nicotinamide, an inhibitor of PARS activity, on gut and liver O2 exchange and energy metabolism during hyperdynamic porcine endotoxemia.

M Theisen1, K Träger, I Tugtekin, A Stehr, F Ploner, M Georgieff, P Radermacher, M Matĕjovic.   

Abstract

OBJECTIVE: To investigate the effects of nicotinamide (NIC), an inhibitor of poly(ADP-ribose) synthetase (PARS), on intestinal and liver perfusion, O2 kinetics, and energy metabolism over 24 h of hyperdynamic porcine endotoxemia.
DESIGN: Prospective, randomized, controlled experimental study with repeated measures.
SETTING: Animal laboratory in a university hospital.
SUBJECTS: Sixteen pigs, divided into two groups: nine endotoxemic animals without therapy (CON); seven animals treated with NIC.
INTERVENTIONS: Pigs were anesthetized, mechanically ventilated, and instrumented. Intravenous E. Coli LPS was continuously infused over 24 h concomitant with fluid resuscitation. After 12 h of endotoxemia continuous i.v. infusion of NIC (10 mg/kg per hour) was administered until the end of the experiment. MEASUREMENTS AND
RESULTS: All animals developed hyperdynamic circulation with sustained increase in cardiac output and progressive fall in mean arterial pressure. NIC maintained blood pressure without affecting CO. Hepato-splanchnic macrocirculation was not modified by the treatment. Nevertheless, although NIC attenuated the progressive rise of ileal mucosal-arterial PCO2 gap, it failed to improve portal venous L/P ratio, a marker of the overall energy state of the portal venous drained viscera. Similarly, neither the increased hepatic venous L/P ratio nor the simultaneous drop in hepatic lactate uptake were influenced by NIC.
CONCLUSIONS: Although NIC maintained hemodynamic stabilization during long-term endotoxemia, it was unable to improve LPS-induced deterioration of the hepato-splanchnic energy metabolism. More potent and selective PARS inhibitors are needed to elucidate the role of a PARS-dependent pathway in a clinically relevant models of sepsis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11355130     DOI: 10.1007/s001340000842

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  5 in total

Review 1.  Nicotinamide: a jack of all trades (but master of none?).

Authors:  Csaba Szabó
Journal:  Intensive Care Med       Date:  2003-04-24       Impact factor: 17.440

2.  Plasma disappearance of indocyanine green: a marker for excretory liver function?

Authors:  Alexander Stehr; Franz Ploner; Karl Traeger; Marc Theisen; Carl Zuelke; Peter Radermacher; Martin Matejovic
Journal:  Intensive Care Med       Date:  2005-10-18       Impact factor: 17.440

3.  Effect of combining nicotinamide as a PARS-inhibitor with selective iNOS blockade during porcine endotoxemia.

Authors:  A Stehr; F Ploner; I Tugtekin; M Matejovic; M Theisen; C Zülke; M Georgieff; P Radermacher; K-W Jauch
Journal:  Intensive Care Med       Date:  2003-05-09       Impact factor: 17.440

4.  Nicotinamide increases systemic vascular resistance in ovine endotoxemia.

Authors:  Marion Scharte; Jerzy-Roch Nofer; Hugo Van Aken; Rene Waurick; Jörg Meyer; Hans-Georg Bone
Journal:  Intensive Care Med       Date:  2003-05-01       Impact factor: 17.440

5.  Nicotinamide does not influence cytokines or exhaled NO in human experimental endotoxaemia.

Authors:  A Soop; J Albert; E Weitzberg; A Bengtsson; C-G Nilsson; A Sollevi
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.